Beam Therapeutics, Inc. (BEAM)

31.99 -2.27 (-6.63%) USD  |  NASDAQ  |  Jan 23, 15:40
More

Beam Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade